Cancer Clinical Trials
Cancer clinical trials may open new doors of cancer screening, diagnosis and treatment options for you and your loved ones. Oftentimes, these innovative studies can offer better options for specific circumstances than the current standard of care.
Today’s patients discover new hope for better outcomes and quality of life through clinical trials. Future patients benefit from the lessons learned that lead to improved treatment options and cure rates.
What is a Clinical Trial?
A clinical trial – also known as a clinical research study – is designed to answer specific questions about drugs, vaccines, and medical devices, as well as find new ways of using current treatments for other medical conditions. Clinical drug trials help determine if new treatments are both safe and effective, and are the safest way to find treatments that work.
Before testing can begin in humans through a clinical trial, extensive research must be conducted in animal and human cells. If all testing proves successful and promising, sponsors of the clinical trial must receive Food and Drug Administration (FDA) approval before starting to test through a clinical trial.
Interested in learning more about clinical trials? View our participant information or call the Avera Cancer Institute Navigation Center at 888-422-1410.
Clinical Trials for Innovative Cancer Treatment
Through Avera Cancer Institute’s affiliation with the National Cancer Institute and NRG Oncology, Avera patients benefit from access to a variety of innovative treatment options through clinical trials. View our complete list of oncology studies currently enrolling patients and learn more about our Breast Cancer Collaborative Registry.
Avera Cancer Institute Sioux Falls
Basic Research Studies
Contact Research Coordinators at (605)322-3228 or (605)322-3018 for more information
Brain Cancer Studies
Breast Cancer Studies
Contact Breast Research Coordinators at (605)322-3295 or (605)322-3291 or email breastresearch@avera.org for more information
Cancer Care Delivery Studies
Contact Research Coordinators at (605)322-3221 or (605)322-3291 for more information
Cancer Screening
Contact Research Coordinators at (605)322-3221 or (605)322-3291 for more information
Colorectal Cancer Studies
Genetics Studies
Contact Research Coordinators at (605)322-3228 or (605)322-3291 for more information
Gynecologic Cancer Studies
Contact Research Coordinators at (605)322-7536 or (605)322-7554 or email gynresearch@avera.org for more information
Leukemia Studies
Contact Research Coordinators at (605)322-3086 or (605)322-3018 or email hemresearch@avera.org for more information
Lung Cancer Studies
Lymphoma Studies
Contact Research Coordinators at (605)322-3086 or (605)322-3018 or email hemresearch@avera.org for more information
Melanoma Studies
Multiple Myeloma Studies
Contact Research Coordinators at (605)322-3086 or (605)322-3018 or email hemresearch@avera.org for more information
Myelodysplastic Syndrome Studies
Contact Research Coordinators at (605)322-3086 or (605)322-3018 or email hemresearch@avera.org for more information
Myelofibrosis
Pancreatic Cancer Studies
Prostate Cancer Studies
Renal/Urinary Tract Cancer Studies
Hepatocellular/Liver Cancer Studies
Transplant/Transfusion Studies
Contact Research Coordinator at (605)322-3016 for more information.
Immunotherapy Studies
Contact Research Coordinators at (605)322-3086 or (605)322-3291 for more information
Cancer Control Studies
Cancer Registry Studies
Contact Research Coordinators at (605)322-3086 or (605)322-3295 or (605)322-3018 or (605)322-3295 for more information
Avera Cancer Institute Aberdeen
Brain Cancer Studies
Breast Cancer Studies
Colorectal Cancer Studies
Genetics Studies
Lung Cancer Studies
Multiple Myeloma Studies
Renal/Urinary Tract Cancer Studies
Cancer Control Studies
Cancer Registry Studies
Avera Cancer Institute Marshall
Avera Cancer Institute Mitchell
